7/13/2021 8:18:42 AM
Hoth Therapeutics: HT-003 Group Of Assets Yields Positive Results In An In Vivo Acne Therapeutic Model
6/28/2021 8:12:00 AM
Hoth Therapeutics Announces Positive Results From AD001 Cohort 1 Of Phase 1b Trial Of BioLexa For Atopic Dermatitis
6/3/2021 8:09:32 AM
Hoth Therapeutics Shares Positive Preclinical Results Of Novel HT-KIT Therapeutic
5/5/2021 9:27:33 AM
Hoth Therapeutics, Virginia Commonwealth University Expand Research Agreement For COVID-19 Therapeutic
4/22/2021 9:13:55 AM
Hoth Says Its First In Human Clinical Trial For Treatment Of Atopic Dermatitis With BioLexa Underway
4/20/2021 9:12:02 AM
Hoth Announces MRNA Frame Shifting Therapeutic Significantly Inhibits Tumor Growth In Mast Cell-Derived Cancers
4/6/2021 9:20:16 AM
Hoth Engages Clinical Trials As Contract Research Organization For Phase 2a HT-001 Trial For Cancer Patients
4/5/2021 8:20:15 AM
Hoth Announces Notice Of Allowance For New Patent Application Related To Method For Inhibiting Formation Of Biofilm
3/24/2021 8:28:33 AM
Voltron Therapeutics Reports Positive Data From Animal Testing Of Its HaloVax SAV Against COVID-19
3/23/2021 8:09:42 AM
Hoth Therapeutics Announces Positive Preclinical Results For Novel COVID-19 Therapeutic; Stock Surges
3/11/2021 9:16:40 AM
Hoth Executes Deal To Assess Effect Of HT-003 Therapeutic Platform On Ulcerative Colitis And Crohn's Disease
2/23/2021 8:17:05 AM
Hoth Says Successfully Completed Pre-IND Meeting With FDA On Proposed Development Of HT-001 For Cancer Patients
2/18/2021 8:11:12 AM
Hoth Therapeutics' HT-003 Shows Anti-inflammatory Benefits
1/28/2021 8:25:33 AM
Hoth Expands Research Deal With Weill Cornell Medicine To Continue Advancement Of HT-003 For Acne Treatment